Tag Archives: biologics for rheumatoid arthritis

rheumatoid arthritis research briefs remission exercise

RA Research Briefs: Remission, Biologics, Exercise

Keep up-to-date on the latest rheumatoid arthritis (RA) research with our brief research summaries.

Smoking, Obesity Make RA Harder to Control

Remission in RA patients can be harder to achieve in those who are overweight or smoke, according to a recent study. American and Canadian researchers who collected data on more than 1,100 patients receiving standard treatment for RA found that sex (being female), excess weight and smoking were not significantly associated with symptom severity early on. However, all three factors influenced how much symptoms improved over time. The most dramatic differences in symptoms were seen in patients who were overweight or obese and smoked, the study found.

Source: ACR/ARHP Annual Meeting, November 2016

Continue reading RA Research Briefs: Remission, Biologics, Exercise

rheumatoid arthritis green tea

RA Research Briefs: Remission, Surgery, Green Tea

Keep up-to-date on the latest rheumatoid arthritis (RA) research with our brief research summaries.

Obesity Reduces Odds of RA Remission

Research suggests weight may be a factor in whether people with RA will achieve disease remission. A review of studies screened a total 3,368 patient records. Canadian researchers found obese patients with RA were less likely to achieve remission or sustain remission compared to healthy-weight patients. Obesity, they reported, negatively impacts disease activity and patient-reported outcomes during therapy. Therefore, they say, interventions to reduce BMI should be investigated for the ability to improve disease outcomes.

Source: Arthritis Care & Research, January 2017

Continue reading RA Research Briefs: Remission, Surgery, Green Tea

Anti TNF RA Flare

Study: Risk of Rheumatoid Arthritis Flare Triples in People Who Stop Anti-TNFs

Biologic drugs make it possible for many people with inflammatory types of arthritis, such as rheumatoid arthritis (RA), to achieve low disease activity or remission. But because of the drugs’ cost and the potential for serious side effects, many patients don’t want to stay on them indefinitely, so researchers have been looking at whether it’s possible to taper or stop them. A new study, published recently in Arthritis & Rheumatology, is adding to the growing body of research on the topic.
Continue reading Study: Risk of Rheumatoid Arthritis Flare Triples in People Who Stop Anti-TNFs